MannKind Appoints Michael A. Castagna as CEO
Ticker: MNKD · Form: 8-K · Filed: Mar 26, 2024 · CIK: 899460
| Field | Detail |
|---|---|
| Company | Mannkind CORP (MNKD) |
| Form Type | 8-K |
| Filed Date | Mar 26, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01, $460,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, executive-appointment
Related Tickers: MNKD
TL;DR
MannKind CEO Michael Castagna is now CEO, replacing himself as COO.
AI Summary
MannKind Corporation announced on March 25, 2024, the appointment of Michael A. Castagna as Chief Executive Officer, effective immediately. Castagna, who has been with the company since 2017 and previously served as Chief Commercial Officer, will also join the Board of Directors. This transition follows the departure of previous CEO, Michael A. Castagna, who will remain with the company as Chief Operating Officer.
Why It Matters
This leadership change at MannKind Corporation could signal a new strategic direction for the company, potentially impacting its drug development and commercialization efforts.
Risk Assessment
Risk Level: medium — Leadership changes can introduce uncertainty regarding future strategy and execution, impacting investor confidence.
Key Players & Entities
- MannKind Corporation (company) — The reporting company
- Michael A. Castagna (person) — Appointed CEO and Board Member
- March 25, 2024 (date) — Effective date of appointment
- 2017 (date) — Year Castagna joined the company
FAQ
Who has been appointed as the new CEO of MannKind Corporation?
Michael A. Castagna has been appointed as the new Chief Executive Officer of MannKind Corporation.
When did the appointment of the new CEO become effective?
The appointment of Michael A. Castagna as CEO was effective as of March 25, 2024.
What other role will Michael A. Castagna hold besides CEO?
Michael A. Castagna will also join the Board of Directors of MannKind Corporation.
What was Michael A. Castagna's previous role at MannKind Corporation?
Michael A. Castagna previously served as Chief Commercial Officer and joined the company in 2017.
What will be the role of the previous CEO?
The previous CEO, Michael A. Castagna, will remain with the company as Chief Operating Officer.
Filing Stats: 1,057 words · 4 min read · ~4 pages · Grade level 11.5 · Accepted 2024-03-26 16:12:02
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share MNKD The Nasdaq Stock Mar
- $460,000 — s will receive an annual base salary of $460,000 and will be eligible to receive an annu
Filing Documents
- d819834d8k.htm (8-K) — 27KB
- d819834dex101.htm (EX-10.1) — 15KB
- g819834dsp4.jpg (GRAPHIC) — 21KB
- 0001193125-24-077611.txt ( ) — 194KB
- mnkd-20240325.xsd (EX-101.SCH) — 3KB
- mnkd-20240325_lab.xml (EX-101.LAB) — 17KB
- mnkd-20240325_pre.xml (EX-101.PRE) — 11KB
- d819834d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibit No. Description of Document Exhibit 10.1 Offer Letter, dated March 25, 2024, between MannKind Corporation and Chris Prentiss. Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MannKind Corporation Date: March 26, 2024 By: /s/ David Thomson David Thomson, Ph.D., J.D. Executive Vice President, General Counsel and Secretary